Invesque Inc (TSE:IVQ)
TSX:IVQ
Top Page
Invesque
(TSX:IVQ)
Select Model
Select Model
Rating:41Neutral
Price Target:
C$0.12
▼(-4.62% Downside)
Action:ReiteratedDate:03/21/26
The score is weighed down primarily by weak financial performance (shrinking revenue, ongoing losses, and TTM cash flow turning negative), with only a partial offset from improved leverage. Technicals are neutral with slight bearish momentum, and valuation remains unattractive/unclear due to negative earnings and no dividend yield data.
Positive Factors
Improved Leverage
A meaningful reduction in leverage from historically high levels to about 0.4x materially lowers refinancing and interest-rate risk and increases financial flexibility. This strengthens the firm’s ability to execute asset-level turnarounds, fund JV activity or withstand cyclic stress over the medium term.
Negative Factors
Multi-year Revenue Decline
A sustained multi-year revenue contraction, including a sharp TTM decline near 31%, reduces scale and weakens fixed-cost absorption. That trend constrains recurring cash flows, limits reinvestment capacity, and increases the risk that recovery will require operational change or asset sales to restore growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved Leverage
A meaningful reduction in leverage from historically high levels to about 0.4x materially lowers refinancing and interest-rate risk and increases financial flexibility. This strengthens the firm’s ability to execute asset-level turnarounds, fund JV activity or withstand cyclic stress over the medium term.
Read all positive factors
Invesque (IVQ) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$116.53M
Dividend YieldN/A
Average Volume (3M)48.16K
Price to Earnings (P/E)―
Beta (1Y)-0.69
Revenue Growth-33.25%
EPS Growth90.14%
CountryCA
Employees1,448
SectorReal Estate
Sector Strength53
IndustryReal Estate - Services
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding832,358,800
10 Day Avg. Volume74,239
30 Day Avg. Volume48,155
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)1.06
Price to Sales (P/S)1.26
P/FCF Ratio-7.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Invesque Business Overview & Revenue Model
Company Description
Invesque Inc. operates as a health care real estate investment company. Its portfolio includes investments in independent living, assisted living, memory care, skilled nursing, transitional care, and medical office properties. As of March 11, 2022...
How the Company Makes Money
Invesque makes money primarily through real estate cash flows and investment returns associated with its healthcare property portfolio. Key revenue and earnings drivers typically include: (1) Rental/lease income from healthcare real estate: When I...
Invesque Financial Statement Overview
Summary
Income Statement
28
Negative
Balance Sheet
35
Negative
Cash Flow
32
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 79.44M | 162.67M | 188.75M | 198.03M | 210.45M |
| Gross Profit | 29.39M | 59.00M | 72.41M | 95.59M | 90.97M |
| EBITDA | -9.72M | 24.27M | -18.83M | 10.38M | 49.13M |
| Net Income | -32.04M | -36.14M | -99.24M | -42.01M | -28.54M |
Balance Sheet | |||||
| Total Assets | 130.80M | 637.22M | 828.28M | 1.10B | 1.30B |
| Cash, Cash Equivalents and Short-Term Investments | 39.26M | 18.16M | 10.74M | 27.58M | 19.37M |
| Total Debt | 33.52M | 394.84M | 588.25M | 765.46M | 893.75M |
| Total Liabilities | 36.69M | 518.05M | 681.18M | 865.69M | 1.01B |
| Stockholders Equity | 94.11M | 119.17M | 146.59M | 231.65M | 286.26M |
Cash Flow | |||||
| Free Cash Flow | -14.26M | 4.40M | 217.00K | 5.40M | 11.11M |
| Operating Cash Flow | -11.66M | 9.27M | 6.03M | 11.91M | 18.68M |
| Investing Cash Flow | 397.12M | 152.21M | 132.05M | 137.49M | 119.19M |
| Financing Cash Flow | -363.91M | -154.07M | -154.92M | -141.19M | -152.63M |
Invesque Technical Analysis
Positive
0.13
Price Trends
0.13
Positive
0.13
Positive
0.13
Positive
Market Momentum
<0.01
Negative
61.39
Neutral
77.78
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:IVQ, the sentiment is Positive. The current price of 0.13 is below the 20-day moving average (MA) of 0.13, below the 50-day MA of 0.13, and above the 200-day MA of 0.13, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 61.39 is Neutral, neither overbought nor oversold. The STOCH value of 77.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:IVQ.
Invesque Peers Comparison
UnderperformOutperform
Sector (65)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | C$1.64B | 8.83 | 17.29% | 0.09% | 10.61% | 43.64% | |
66 Neutral | C$34.78M | 7.07 | 4.41% | 2.31% | 2.03% | ― | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
61 Neutral | C$127.70M | 4.79 | 9.18% | ― | ― | ― | |
53 Neutral | C$1.61B | -136.04 | -2.63% | 0.25% | 9.98% | 93.01% | |
53 Neutral | C$128.51M | 17.25 | -8.54% | 10.31% | 58.15% | -235.04% | |
41 Neutral | C$116.53M | -3.12 | -28.36% | ― | -33.25% | 90.14% |
* Real Estate Sector Average
TSE:IVQ
Invesque
0.14
-0.05
-26.32%
TSE:IEI
Imperial Equities
3.68
0.16
4.55%
TSE:MEQ
Mainstreet Equity
176.51
-9.80
-5.26%
TSE:SVI
Storagevault Canada
4.41
0.67
17.91%
TSE:PKT
Parkit Enterprise
0.60
0.21
53.85%
TSE:BRE
Bridgemarq Real Estate Services
13.55
1.37
11.22%
Invesque Corporate Events
Business Operations and StrategyFinancial DisclosuresM&A Transactions
Invesque Accelerates Asset Sales and Cuts Debt as Revenue Declines
Negative
Mar 19, 2026
Invesque reported a sharp reduction in its portfolio to seven owned assets at year-end 2025 after a series of asset disposals across the U.S. and Canada, including seniors housing properties and a medical office building. The company also fully re...
Business Operations and StrategyDelistings and Listing Changes
Invesque Retires US$27.3 Million High-Coupon Debentures, Streamlining Capital Structure
Positive
Jan 26, 2026
Invesque Inc. has fully redeemed its US$27.3 million 9.75% unsecured subordinated debentures due December 30, 2027, with the securities retired on January 23, 2026 and subsequently delisted from the Toronto Stock Exchange. The move streamlines Inv...
Business Operations and StrategyDelistings and Listing Changes
Invesque Retires US$27.3 Million High-Coupon Debentures, Streamlining Capital Structure
Positive
Jan 26, 2026
Invesque Inc. has fully redeemed its US$27.3 million 9.75% unsecured subordinated debentures, which were due December 30, 2027, and has had the debentures delisted from the Toronto Stock Exchange following the January 23, 2026 redemption. The tran...
Business Operations and StrategyM&A Transactions
Invesque Sells Nine Seniors Properties, Moves to Redeem US$27.3 Million Debentures
Positive
Dec 29, 2025
Invesque Inc. has accelerated its portfolio restructuring by disposing of nine properties in December, including four U.S. seniors housing assets sold for US$57 million, a medical office building in New York sold for US$4.1 million, and its only C...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.